panitumumab
takeda,amgen
['kudos', 'triplet', 'triplete', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'improve ']
#triplete #asco22 mfolfoxiri+pani did not improve orr (73% vs 76%, p=0.526) in ras braf wt mcrc patients kudos to for her huge leadership and the great presentation 
MD, PhD. GI Medical Oncologist @istitutotumori. @myESMO #YOC & #SoMe committee member. European. Beauty seeker. #endowarrior. Tweets are my own.